Organization · Venture Capital
TauTona Group
TauTona Group is a vertically-integrated operational fund based in Redwood City, California, focused on creating, investing in, and developing innovative solutions in medtech, biotech, and regenerative medicine. Founded in 2010 by Stanford professors, it aims to address unmet clinical needs in healthcare.
Overview
What TauTona Group does
What TauTona Group is
TauTona Group is a vertically-integrated operational fund based in Redwood City, California, focused on creating, investing in, and developing innovative solutions in medtech, biotech, and regenerative medicine. Founded in 2010 by Stanford professors, it aims to address unmet clinical needs in healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find TauTona Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
TauTona Group as a funder
Investment thesis
TauTona Group focuses on creating and developing innovative medical technologies to address unmet clinical needs, particularly in smaller healthcare markets that are often overlooked by larger VC funds.
Focus narrative
The focus of TauTona Group is on investing in and developing innovative medical technologies that improve healthcare outcomes while reducing costs. Their sustainable investment model supports the entire lifecycle of product development, from ideation to commercialization, emphasizing a differentiated development process to de-risk projects.
Value beyond capital
TauTona Group adds value to its portfolio companies by providing clinical insights, shared R&D resources, and a de-risked development process. Their operational model allows for direct investment into product development, facilitating faster and more efficient commercialization of medical technologies.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Sectors
- Biotech · Medical Devices
- Regions
- United States · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Thread Tech and Tissue Injector
Portfolio context
Notable products developed by TauTona Group include the Pneumoperitoneum Assist Device (TPAD), which supports minimally invasive surgery; the BioBolt Surgical Stapler, designed for faster and more reliable hernia fixation; and the TauTona Wound Dressing (TWD), a hydrogel platform that promotes moist healing and biocompatibility.
Common questions
What to know about TauTona Group
Upseed classifies TauTona Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.